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Previewsautophagy was attenuated, in peripheral
blood mononuclear cells from a patient
with a mutation in PIK3CD/p110d, which
is associated with overactivation of
mTOR (Lucas et al., 2014). Finally, treat-
ment with rapamycin stimulated auto-
phagy and decreased IL1B secretion in
the patient’s cells. These results suggest
that autophagy regulation by the axis
comprised of TORC1 and the mRNA de-
capping complex is involved in fungal
infection, the immune response, and the
pathogenesis of human diseases.
Thus, Hu et al. revealed a highly
conserved post-transcriptional mecha-
nism in which autophagy gene transcripts
are destabilized by a decapping enzyme
complex activated by TORC1 under
nutrient-rich conditions. Starvation termi-
nates this degradation pathway through
inactivation of TORC1. In concert with
previously described mechanisms that
upregulate transcription of ATG genes in
response to starvation, this mechanism
should allow cells to rapidly induce auto-
phagy under these conditions. Although
Dcp2 is the direct target of TORC1-medi-
ated phosphorylation, it is Dhh1/Vad1/134 Developmental Cell 34, July 27, 2015 ª2DDX6 that associates with substrate
mRNAs. Thus, further analysis will be
required to elucidate how TORC1-depen-
dent phosphorylation leads to the associ-
ation of the Dcp2-Dhh1/Vad1/DDX6
complex with ATG transcripts. Features
in ATG transcripts that are recognized
by this complex also remain to be deter-
mined. Although this study focused on
ATG genes, whose products drive auto-
phagosome formation, other gene tran-
scripts encoding proteins involved in
other steps in autophagy, including auto-
phagosome-lysosome/vacuole fusion
and degradation in lysosomes/vacuoles,
may also be targets for this degradation
pathway. One or more phosphatases
that dephosphorylates Dcp2 to accel-
erate inactivation of this pathway may
also exist. Future studies should address
these interesting issues raised by this
study.
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Chronic inflammation is associated with tumorigenesis, but how acute inflammation affects the tumor micro-
environment is less known. Recently, Antonio et al. (2015) found that neutrophils attracted to an acute wound
such as a biopsy drive cell proliferation of nearby pre-neoplastic cells, suggesting that acute wounds may
promote cancer progression.Cancer is oftendescribedasan ‘‘unhealed
wound,’’ as chronic inflammation is a hall-
mark of the tumor microenvironment. In
fact, unresolved inflammation can pro-
mote tumorigenesis—there are well-
documented links, for example, between
chronic H. pylori infection and stomach
cancer, inflammatory bowel disease and
colon cancer, and chronic hepatitis infec-
tion and hepatocellular carcinoma. In
other cases, however, immunity andinflammation have beneficial effects and
can control tumor growth. Neutrophils
are first responders to sites of acute tissue
damage, but they are also present in
chronicwounds and in the tumormicroen-
vironment, and they have both pro- and
anti-tumor functions (Tecchio et al.,
2013). There remain gaps in our under-
standing of how inflammation influences
the tumor microenvironment and what
factors promote the beneficial or detri-mental effects of neutrophils. In particular,
how do acute wounds, such as tumor bi-
opsies, which are commonly performed
during the diagnosis of cancer, affect can-
cer progression? This question, and the
role of neutrophils in this process, is
elegantly addressed in work published
recently by Antonio et al. (2015) that used
a zebrafish model of RasG12V-induced
neoplasia in skin cells (Feng et al., 2010,
2012; Michailidou et al., 2009).
Figure 1. Schematic of Neutrophil-Transformed Cell Interactions after Acute Wounding
After an acute injury, both neutrophils and macrophages infiltrate the wound (1). Unknown signals at the
wound influence neutrophils to adopt an anti-inflammatory ‘‘N2’’ phenotype (2). As the wound heals,
macrophage inflammation resolves (3), but Antonio et al. find that, if there are nearby cancer cells (as in
a tumor biopsy), the N2 neutrophils are ‘‘distracted’’ by and interact with these nearby cancer cells (4).
The presence of these neutrophils promotes proliferation of the cancer cells through signals such as
PGE2, creating a pro-tumor microenvironment. This suggests that biopsies could be detrimental to the
treatment of cancer patients. Future research should focus on how the phenotype of these neutrophils
could be optimized to instead inhibit cancer progression. Pro-growth and trophic signals could be directly
inhibited by treatment with Cox inhibitors such as aspirin (a), neutrophils could be pushed toward an ‘‘N1’’
or anti-tumor phenotype by treatment with pro-inflammatory stimuli such as LPS (b), or treatments could
promote the reverse-migration and resolution of these neutrophils, either directly or by activating subsets
of macrophages that repel neutrophils from the wound (c).
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PreviewsExpression of oncogenic RasG12V in
zebrafish skin melanocytes or epidermal
cells induces cell transformation and
recruitment of neutrophils, which drive
cell proliferation (Feng et al., 2010) and
expression of EMT markers (Freisinger
and Huttenlocher, 2014). In the current
study, Antonio et al. first demonstrate
that chronic tissue damage drives cancer
progression; repeatedly wounding adult
zebrafish expressing RasG12V inmelano-
cytes significantly increased tumor forma-
tion. Turning their attention to the effect
of an acute wound in an already chroni-
cally ‘‘wounded’’ tumor microenviron-
ment, Antonio et al. found that biopsying
sections of these skin tumors increased
neutrophil infiltration around neighboring
RasG12V+ cells.
To more carefully quantify the link be-
tween acute wound-induced inflamma-
tion and pre-neoplastic cell growth, Anto-
nio et al. utilized larval zebrafish,where the
tumor microenvironment can be imaged
in real time. The authors observed that
neutrophils migrating to a nearby laser
wound were ‘‘distracted’’ by RasG12V+
cells, such that twice as many RasG12V+cells adjacent to a wound are visited by
neutrophils compared to RasG12V+ cells
in an unwounded area, and these neutro-
phils develop sustained interactions with
the RasG12V+ cells. Importantly, this
acute wound increased the proliferation
of nearby existing clones of RasG12V+
cells. Unlike in an unwounded setting, in
which the chronic inflammation of both
macrophages and neutrophils promotes
the growth of these pre-neoplastic
cells (Feng et al., 2012), this acute
wound-induced proliferation was specif-
ically dependent on neutrophil infiltration:
neutrophil depletion with a morpholino
against GCSF, but not macrophage
depletion with an irf8 morpholino, in-
hibited this proliferation. It should be
noted, however, that depletion of GCSF
might independently affect tumor growth,
since some cancer cells upregulate the
GCSF receptor (Liongue et al., 2009).
Thus, these results should be confirmed
in other neutrophil-depleted settings.
How do wound-sensitized neutrophils
promote tumor progression? What sig-
nals are they delivering to these RasG12V
cells? Based on previous work, theDevelopmental Ceauthors focused on prostaglandin-E2
(PGE2) as a possible trophic signal (Feng
et al., 2012). Application of a PGE2 analog
in the context of immune depletion
partially rescued RasG12V+ cell prolifera-
tion. Additionally, treatment with a Cox-2
inhibitor, which dampens the production
of PGE2, partially inhibited wounding-
induced cell proliferation, suggesting that
Cox inhibitors, including non-steroidal
anti-inflammatories (NSAIDs) and aspirin,
could limit the pro-tumor effect of an acute
wound in patients post-biopsy. PGE2may
also be involved in signaling to neutrophils
because PGE2 affects the function and
behavior of many immune cells.
Larval zebrafish lack an adaptive im-
mune response, allowing Antonio et al.
to focus specifically on the role of innate
immune cells in driving cancer growth
near an acute wound. However, both neu-
trophils and macrophages can activate
(or suppress) T cells and other adaptive
immune cells, and it will be interesting
in future studies to determine whether
the role of neutrophils and macrophages
is altered in adult zebrafish or other organ-
isms with an adaptive immune response.
In this study the authors found that, as in
larval zebrafish, the level of neutrophil,
but not macrophage, infiltration in human
patient melanoma samples was corre-
lated with tumor cell proliferation. In fact,
neutrophil infiltration can be used as a
prognostic indicator for patients and is
strongly correlated with ulceration status
of the melanoma, another known prog-
nostic indicator.
Overall, these findings suggest that
acute wounds, such as biopsies, recruit
more neutrophils to a tumor site, which
in turn promotes proliferation of pre-
neoplastic cells (Figure 1). What is
different about a neutrophil after visiting
an acute wound that makes it even more
detrimental in a chronic tumor environ-
ment? Future research should focus on
how to alter the wound- and tumor-asso-
ciated neutrophil phenotype to fight,
instead of promote, tumor growth.
Encouragingly, these data suggest that
the effect of an acute wound on pre-
neoplastic cell proliferation can be miti-
gated by treatment with Cox inhibitors
such as aspirin. More directed treatments
to promote resolution of neutrophil
inflammation should also be explored,
including inducing neutrophils to leave
the wound and reverse-migrate backll 34, July 27, 2015 ª2015 Elsevier Inc. 135
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Previewsinto the vasculature (Mathias et al., 2006;
Robertson et al., 2014). Targeting macro-
phages to induce neutrophil resolution or
clearance is an intriguing possibility, as
subsets of macrophages have been
shown to repel neutrophils from a wound
(Tauzin et al., 2014). Another possibility
is to harness neutrophil inflammation by
driving neutrophils toward an anti-tumor
‘‘N1’’ phenotype instead of a pro-tumor
‘‘N2’’ one. How does a nearby infection
alter the phenotype of neutrophils in
response to a tumor? Application of LPS
or other bacterial products could be
used to alter the tumor microenvironment
to a more anti-cancer function. These
questions are very relevant to the clinical136 Developmental Cell 34, July 27, 2015 ª2setting, where increased tumor growth
might be an unintended consequence of
a biopsy.REFERENCES
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